These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Severe skin necrosis produced by piperazinedione extravasation. Brenner DE; Aisner J; Wiernik PH Cancer Treat Rep; 1980; 64(12):1392-4. PubMed ID: 6258792 [No Abstract] [Full Text] [Related]
43. A large hypopigmented skin lesion following extravasation of intravenous fluid. Hon KL; Chow CM; Li A; Leung AK Adv Ther; 2007; 24(5):983-6. PubMed ID: 18029323 [TBL] [Abstract][Full Text] [Related]
44. Case of skin necrosis due to arginine monohydrochloride extravasation. Bassi E; Lonati D; Pandolfi R; Gatti M; Jolliffe VM; Del Forno C J Dermatol; 2007 Mar; 34(3):198-200. PubMed ID: 17291302 [TBL] [Abstract][Full Text] [Related]
45. Intravenous extravasation injuries: the effectiveness of hyaluronidase in their treatment. Laurie SW; Wilson KL; Kernahan DA; Bauer BS; Vistnes LM Ann Plast Surg; 1984 Sep; 13(3):191-4. PubMed ID: 6497266 [TBL] [Abstract][Full Text] [Related]
46. Treatment options in extravasation injury: an experimental study in rats. Yilmaz M; Demirdover C; Mola F Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569 [TBL] [Abstract][Full Text] [Related]
47. Early surgical suction and washout for treatment of cytotoxic drug extravasations. Vandeweyer E; Deraemaecker R Acta Chir Belg; 2000 Feb; 100(1):37-8. PubMed ID: 10776527 [TBL] [Abstract][Full Text] [Related]
48. [The significance of extravasation in oncological care]. Zatkóné Puskás G Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301 [TBL] [Abstract][Full Text] [Related]
50. [Prevention of extravasation necroses as a complication following intravenous cytostatic drug therapy. Results of an open pilot study]. Kolarić K; Zupanc D; Stahl KW; Hinz J; Kempf SR; Ivankovic S Onkologie; 1988 Oct; 11(5):238-40. PubMed ID: 3059251 [TBL] [Abstract][Full Text] [Related]
51. Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G Lancet Oncol; 2006 Feb; 7(2):186-7. PubMed ID: 16455484 [No Abstract] [Full Text] [Related]
53. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion. Comas D; Mateu J Ann Pharmacother; 1996 Mar; 30(3):244-6. PubMed ID: 8833558 [TBL] [Abstract][Full Text] [Related]
54. Deep dopamine extravasation injury: a case report. Phillips RA; Andrades P; Grant JH; Ray PD J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):e222-4. PubMed ID: 19121615 [TBL] [Abstract][Full Text] [Related]
55. The wash-out technique in the management of delayed presentations of extravasation injuries. Dionyssiou D; Chantes A; Gravvanis A; Demiri E J Hand Surg Eur Vol; 2011 Jan; 36(1):66-9. PubMed ID: 20682583 [TBL] [Abstract][Full Text] [Related]
56. Severe Extravasation Injuries in Neonates: A Report of 34 Cases. Kostogloudis N; Demiri E; Tsimponis A; Dionyssiou D; Ioannidis S; Chatziioannidis I; Nikolaidis N Pediatr Dermatol; 2015; 32(6):830-5. PubMed ID: 26337780 [TBL] [Abstract][Full Text] [Related]
57. Compartment syndrome in the hand due to extravasation of contrast material. Selek H; Ozer H; Aygencel G; Turanli S Arch Orthop Trauma Surg; 2007 Aug; 127(6):425-7. PubMed ID: 17021757 [TBL] [Abstract][Full Text] [Related]
58. Surgical management after doxorubicin and epirubicin extravasation. Fleming A; Butler B; Gault D J Hand Surg Br; 1999 Jun; 24(3):390. PubMed ID: 10433467 [No Abstract] [Full Text] [Related]
59. Cutaneous necrosis induced by extravasation of arginine monohydrochloride. Amano H; Nagai Y; Kowase T; Ishikawa O Acta Derm Venereol; 2008; 88(3):310-1. PubMed ID: 18480949 [No Abstract] [Full Text] [Related]